US 10183933
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
granted A61PA61P21/02A61P25/00
Quick answer
US patent 10183933 (Isoindolinone inhibitors of phosphatidylinositol 3-kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P21/02, A61P25/00, A61P25/08, A61P25/14